Clinical Trial

Cannabis and Opioid Use Disorder

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study plans to enroll participants with opioid use disorder who are not currently seeking treatment to assess the effects of cannabis on opioid withdrawal and other related outcomes.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2023-02-06; most recent amendment 2026-06-16.
Status change: Not Yet Recruiting → Recruiting 2024-09-11
Trial Details
NCT Number NCT05729932
Lead Sponsor Shanna Babalonis, PhD
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions Opioid Use Disorder
Enrollment 15 participants
Start Date 2024-09-10
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-18